CORCencora, Inc.

$69B

Q1 2025 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$81.5B+12.8% YoY

Gross Profit

$2.3B2.8% margin

Operating Income

$792M1.0% margin

Net Income

$489M0.6% margin

EPS (Diluted)

$2.50

QoQ Revenue Growth

+3.1%

Cash Flow

Operating Cash Flow

-$2.7B

Free Cash Flow

-$2.8B

Stock-Based Comp.

$70M

Balance Sheet

Total Assets

$69.1B

Total Liabilities

$68.7B

Stockholders' Equity

$227M

Cash & Equivalents

$3.3B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$81.5B	$72.3B	+12.8%
Gross Profit	$2.3B	$2.1B	+5.3%
Operating Income	$792M	$751M	+5.4%
Net Income	$489M	$602M	-18.8%

Revenue Segments

Pharmaceutical Distribution

$72.7B89%

International Healthcare Solutions

$7.5B9%

Animal Health

$1.4B2%

Geographic Segments

U.S. Healthcare Solutions

$74.0B91%

International Healthcare Solutions

$7.5B9%

COR Q1 2025 Earnings — Cencora, Inc. Revenue & Financial Results | Market Cap Arena